COVID-19 Impact on Global Cancer Biologics Market Size, Status and Forecast 2020-2026

July 2020 | 91 pages | ID: C88D74DA54E2EN
QYResearch

Abstracts

This report focuses on the global Cancer Biologics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Biologics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Roche
• Novartis
• Eli Lilly
• Sanofi
• Celgene
• Pfizer
• Bayer
• Johnson & Johnson
• Bristol-Myers Squibb
• Merck
• Amgen

Market segment by Type, the product can be split into

• Monoclonal Antibodies
• Vaccines
• Cell and Gene Therapy
• Others

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cancer Biologics status, future forecast, growth opportunity, key market and key players.
• To present the Cancer Biologics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Biologics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Biologics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cancer Biologics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Monoclonal Antibodies
  1.4.3 Vaccines
  1.4.4 Cell and Gene Therapy
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Cancer Biologics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cancer Biologics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Cancer Biologics Industry
    1.6.1.1 Cancer Biologics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Cancer Biologics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Cancer Biologics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cancer Biologics Market Perspective (2015-2026)
2.2 Cancer Biologics Growth Trends by Regions
  2.2.1 Cancer Biologics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cancer Biologics Historic Market Share by Regions (2015-2020)
  2.2.3 Cancer Biologics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cancer Biologics Market Growth Strategy
  2.3.6 Primary Interviews with Key Cancer Biologics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cancer Biologics Players by Market Size
  3.1.1 Global Top Cancer Biologics Players by Revenue (2015-2020)
  3.1.2 Global Cancer Biologics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cancer Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Biologics Market Concentration Ratio
  3.2.1 Global Cancer Biologics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cancer Biologics Revenue in 2019
3.3 Cancer Biologics Key Players Head office and Area Served
3.4 Key Players Cancer Biologics Product Solution and Service
3.5 Date of Enter into Cancer Biologics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cancer Biologics Historic Market Size by Type (2015-2020)
4.2 Global Cancer Biologics Forecasted Market Size by Type (2021-2026)

5 CANCER BIOLOGICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cancer Biologics Market Size by Application (2015-2020)
5.2 Global Cancer Biologics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cancer Biologics Market Size (2015-2020)
6.2 Cancer Biologics Key Players in North America (2019-2020)
6.3 North America Cancer Biologics Market Size by Type (2015-2020)
6.4 North America Cancer Biologics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cancer Biologics Market Size (2015-2020)
7.2 Cancer Biologics Key Players in Europe (2019-2020)
7.3 Europe Cancer Biologics Market Size by Type (2015-2020)
7.4 Europe Cancer Biologics Market Size by Application (2015-2020)

8 CHINA

8.1 China Cancer Biologics Market Size (2015-2020)
8.2 Cancer Biologics Key Players in China (2019-2020)
8.3 China Cancer Biologics Market Size by Type (2015-2020)
8.4 China Cancer Biologics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cancer Biologics Market Size (2015-2020)
9.2 Cancer Biologics Key Players in Japan (2019-2020)
9.3 Japan Cancer Biologics Market Size by Type (2015-2020)
9.4 Japan Cancer Biologics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cancer Biologics Market Size (2015-2020)
10.2 Cancer Biologics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Biologics Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Biologics Market Size by Application (2015-2020)

11 INDIA

11.1 India Cancer Biologics Market Size (2015-2020)
11.2 Cancer Biologics Key Players in India (2019-2020)
11.3 India Cancer Biologics Market Size by Type (2015-2020)
11.4 India Cancer Biologics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cancer Biologics Market Size (2015-2020)
12.2 Cancer Biologics Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Biologics Market Size by Type (2015-2020)
12.4 Central & South America Cancer Biologics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview and Its Total Revenue
  13.1.3 Roche Cancer Biologics Introduction
  13.1.4 Roche Revenue in Cancer Biologics Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Cancer Biologics Introduction
  13.2.4 Novartis Revenue in Cancer Biologics Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Eli Lilly
  13.3.1 Eli Lilly Company Details
  13.3.2 Eli Lilly Business Overview and Its Total Revenue
  13.3.3 Eli Lilly Cancer Biologics Introduction
  13.3.4 Eli Lilly Revenue in Cancer Biologics Business (2015-2020)
  13.3.5 Eli Lilly Recent Development
13.4 Sanofi
  13.4.1 Sanofi Company Details
  13.4.2 Sanofi Business Overview and Its Total Revenue
  13.4.3 Sanofi Cancer Biologics Introduction
  13.4.4 Sanofi Revenue in Cancer Biologics Business (2015-2020)
  13.4.5 Sanofi Recent Development
13.5 Celgene
  13.5.1 Celgene Company Details
  13.5.2 Celgene Business Overview and Its Total Revenue
  13.5.3 Celgene Cancer Biologics Introduction
  13.5.4 Celgene Revenue in Cancer Biologics Business (2015-2020)
  13.5.5 Celgene Recent Development
13.6 Pfizer
  13.6.1 Pfizer Company Details
  13.6.2 Pfizer Business Overview and Its Total Revenue
  13.6.3 Pfizer Cancer Biologics Introduction
  13.6.4 Pfizer Revenue in Cancer Biologics Business (2015-2020)
  13.6.5 Pfizer Recent Development
13.7 Bayer
  13.7.1 Bayer Company Details
  13.7.2 Bayer Business Overview and Its Total Revenue
  13.7.3 Bayer Cancer Biologics Introduction
  13.7.4 Bayer Revenue in Cancer Biologics Business (2015-2020)
  13.7.5 Bayer Recent Development
13.8 Johnson & Johnson
  13.8.1 Johnson & Johnson Company Details
  13.8.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.8.3 Johnson & Johnson Cancer Biologics Introduction
  13.8.4 Johnson & Johnson Revenue in Cancer Biologics Business (2015-2020)
  13.8.5 Johnson & Johnson Recent Development
13.9 Bristol-Myers Squibb
  13.9.1 Bristol-Myers Squibb Company Details
  13.9.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.9.3 Bristol-Myers Squibb Cancer Biologics Introduction
  13.9.4 Bristol-Myers Squibb Revenue in Cancer Biologics Business (2015-2020)
  13.9.5 Bristol-Myers Squibb Recent Development
13.10 Merck
  13.10.1 Merck Company Details
  13.10.2 Merck Business Overview and Its Total Revenue
  13.10.3 Merck Cancer Biologics Introduction
  13.10.4 Merck Revenue in Cancer Biologics Business (2015-2020)
  13.10.5 Merck Recent Development
13.11 Amgen
  10.11.1 Amgen Company Details
  10.11.2 Amgen Business Overview and Its Total Revenue
  10.11.3 Amgen Cancer Biologics Introduction
  10.11.4 Amgen Revenue in Cancer Biologics Business (2015-2020)
  10.11.5 Amgen Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cancer Biologics Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Biologics Revenue
Table 3. Ranking of Global Top Cancer Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Vaccines
Table 7. Key Players of Cell and Gene Therapy
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Cancer Biologics Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Cancer Biologics Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Cancer Biologics Players to Combat Covid-19 Impact
Table 14. Global Cancer Biologics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Cancer Biologics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Cancer Biologics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Cancer Biologics Market Share by Regions (2015-2020)
Table 18. Global Cancer Biologics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Cancer Biologics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Cancer Biologics Market Growth Strategy
Table 24. Main Points Interviewed from Key Cancer Biologics Players
Table 25. Global Cancer Biologics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Cancer Biologics Market Share by Players (2015-2020)
Table 27. Global Top Cancer Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biologics as of 2019)
Table 28. Global Cancer Biologics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Cancer Biologics Product Solution and Service
Table 31. Date of Enter into Cancer Biologics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Cancer Biologics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Cancer Biologics Market Size Share by Type (2015-2020)
Table 35. Global Cancer Biologics Revenue Market Share by Type (2021-2026)
Table 36. Global Cancer Biologics Market Size Share by Application (2015-2020)
Table 37. Global Cancer Biologics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Cancer Biologics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Cancer Biologics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Cancer Biologics Market Share (2019-2020)
Table 41. North America Cancer Biologics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Cancer Biologics Market Share by Type (2015-2020)
Table 43. North America Cancer Biologics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Cancer Biologics Market Share by Application (2015-2020)
Table 45. Europe Key Players Cancer Biologics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Cancer Biologics Market Share (2019-2020)
Table 47. Europe Cancer Biologics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Cancer Biologics Market Share by Type (2015-2020)
Table 49. Europe Cancer Biologics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Cancer Biologics Market Share by Application (2015-2020)
Table 51. China Key Players Cancer Biologics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Cancer Biologics Market Share (2019-2020)
Table 53. China Cancer Biologics Market Size by Type (2015-2020) (Million US$)
Table 54. China Cancer Biologics Market Share by Type (2015-2020)
Table 55. China Cancer Biologics Market Size by Application (2015-2020) (Million US$)
Table 56. China Cancer Biologics Market Share by Application (2015-2020)
Table 57. Japan Key Players Cancer Biologics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Cancer Biologics Market Share (2019-2020)
Table 59. Japan Cancer Biologics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Cancer Biologics Market Share by Type (2015-2020)
Table 61. Japan Cancer Biologics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Cancer Biologics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Cancer Biologics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Cancer Biologics Market Share (2019-2020)
Table 65. Southeast Asia Cancer Biologics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Cancer Biologics Market Share by Type (2015-2020)
Table 67. Southeast Asia Cancer Biologics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Cancer Biologics Market Share by Application (2015-2020)
Table 69. India Key Players Cancer Biologics Revenue (2019-2020) (Million US$)
Table 70. India Key Players Cancer Biologics Market Share (2019-2020)
Table 71. India Cancer Biologics Market Size by Type (2015-2020) (Million US$)
Table 72. India Cancer Biologics Market Share by Type (2015-2020)
Table 73. India Cancer Biologics Market Size by Application (2015-2020) (Million US$)
Table 74. India Cancer Biologics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Cancer Biologics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Cancer Biologics Market Share (2019-2020)
Table 77. Central & South America Cancer Biologics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Cancer Biologics Market Share by Type (2015-2020)
Table 79. Central & South America Cancer Biologics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Cancer Biologics Market Share by Application (2015-2020)
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Product
Table 84. Roche Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 85. Roche Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Product
Table 94. Eli Lilly Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 95. Eli Lilly Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Product
Table 99. Sanofi Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 100. Sanofi Recent Development
Table 101. Celgene Company Details
Table 102. Celgene Business Overview
Table 103. Celgene Product
Table 104. Celgene Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 105. Celgene Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Product
Table 109. Pfizer Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 110. Pfizer Recent Development
Table 111. Bayer Company Details
Table 112. Bayer Business Overview
Table 113. Bayer Product
Table 114. Bayer Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 115. Bayer Recent Development
Table 116. Johnson & Johnson Business Overview
Table 117. Johnson & Johnson Product
Table 118. Johnson & Johnson Company Details
Table 119. Johnson & Johnson Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 120. Johnson & Johnson Recent Development
Table 121. Bristol-Myers Squibb Company Details
Table 122. Bristol-Myers Squibb Business Overview
Table 123. Bristol-Myers Squibb Product
Table 124. Bristol-Myers Squibb Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 125. Bristol-Myers Squibb Recent Development
Table 126. Merck Company Details
Table 127. Merck Business Overview
Table 128. Merck Product
Table 129. Merck Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 130. Merck Recent Development
Table 131. Amgen Company Details
Table 132. Amgen Business Overview
Table 133. Amgen Product
Table 134. Amgen Revenue in Cancer Biologics Business (2015-2020) (Million US$)
Table 135. Amgen Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cancer Biologics Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Vaccines Features
Figure 4. Cell and Gene Therapy Features
Figure 5. Others Features
Figure 6. Global Cancer Biologics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Cancer Biologics Report Years Considered
Figure 11. Global Cancer Biologics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cancer Biologics Market Share by Regions: 2020 VS 2026
Figure 13. Global Cancer Biologics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cancer Biologics Market Share by Players in 2019
Figure 16. Global Top Cancer Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biologics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cancer Biologics Revenue in 2019
Figure 18. North America Cancer Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cancer Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cancer Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cancer Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cancer Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cancer Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cancer Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 29. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Eli Lilly Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 31. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sanofi Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 33. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Celgene Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 35. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Pfizer Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 37. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bayer Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 39. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Johnson & Johnson Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 41. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 43. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Merck Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 45. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Amgen Revenue Growth Rate in Cancer Biologics Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed